Skip to main content
Dose-response association between salivary cotinine levels and Mycobacterium tuberculosis infection.
- Author(s): Shin, SS
- Laniado-Laborin, R
- Moreno, PG
- Novotny, TE
- Strathdee, SA
- Garfein, RS
- et al.
Published Web Locationhttps://www.ingentaconnect.com/content/iuatld/ijtld/2013/00000017/00000011/art00016;jsessionid=e5nhso358gnm2.x-ic-live-02
No data is associated with this publication.
ObjectiveTo describe the association between salivary cotinine levels and interferon-gamma (IFN-γ) release assay results.
DesignWe conducted a cross-sectional study among injection drug users. Salivary cotinine levels were measured using NicAlert, a semi-quantitative dipstick assay. QuantiFERON©-TB Gold In-Tube (QFT-GIT) was used to determine Mycobacterium tuberculosis infection.
ResultsAmong 234 participants, the prevalence of QFT-GIT positivity for NicAlert cotinine categories 0 (non-smoking), 1 (second-hand smoke exposure or low-level smoking) and 26 (regular smoking) were respectively 42.1%, 46.4% and 65.2% (Ptrend 0.012). We found increasing trends in QFT-GIT positivity (Ptrend 0.003) and IFN-γ concentrations (Spearman's r 0.200, P 0.002) across cotinine levels 0 to 6. In multivariable log-binomial regression models adjusted for education, cotinine levels were not associated with QFT-GIT positivity when included as smoking categories (1 and 26 vs. 0), but were independently associated with QFT-GIT positivity when included as an ordinal variable (prevalence ratio 1.09 per 1 cotinine level, 95%CI 1.021.16).
ConclusionOur findings suggest that a dose-response relationship exists between tobacco smoke exposure and M. tuberculosis infection. Longitudinal studies that use biochemical measures for smoking status are needed to confirm our findings.
Item not freely available? Link broken?Report a problem accessing this item